Bibliografía
1. Goebel A, Barker C, Birklein F, Brunner F, Casale R, Eccleston C, et al. Standards for the diagnosis and management of complex regional pain syndrome: Results of a European Pain Federation task force. Eur J Pain. 2019;23(4):641-51.
2. Korwisi B, Barke A, Treede RD. Evidence- and consensus-based adaption of the IASP complex regional pain syndrome diagnostic criteria to the ICD-11 category of chronic primary pain: a successful cooperation of the IASP with the World Health Organization. Pain. 2021;162(9):2313-4.
3. Goebel A, Birklein F, Brunner F, Clark JD, Gierthmühlen J, Harden N, et al. The Valencia consensus-based adaptation of the IASP complex regional pain syndrome diagnostic criteria. Pain. 2021;162(9):2346-8.
4. Dimova V, Herrnberger MS, Escolano-Lozano F, Rittner HL, Vlckova E, Sommer C, et al. Clinical phenotypes and classification algorithm for complex regional pain syndrome. Neurology. 2020;94(4):e357-e367.
5. Knudsen LF, Terkelsen AJ, Drummond PD, Birklein F. Complex regional pain syndrome: a focus on the autonomic nervous system. Clin Auton Res. 2019;29(4):457-67.
6. Bobaira M, García-Vitoria C, Calvo A, Desé J, Tortosa G, Bayarri V, et al. Actualizaciones en el abordaje terapéutico en el síndrome de dolor regional complejo. Rev Soc Esp Dolor. 2022;29(1):XXXXXX.
7. Bharwani KD, Dik WA, Dirckx M, Huygen FJPM. Highlighting the Role of Biomarkers of Inflammation in the Diagnosis and Management of Complex Regional Pain Syndrome. Mol Diagn Ther. 2019;23(5):615-26.
8. Birklein F, Ajit SK, Goebel A, Perez RSGM, Sommer C. Complex regional pain syndrome - phenotypic characteristics and potential biomarkers. Nat Rev Neurol. 2018;14(5):272-84.
9. Prasad Md A, Chakravarthy Md K. Review of complex regional pain syndrome and the role of the neuroimmune axis. Mol Pain. 2021;17:17448069211006617.
10. Soin A, Soin Y, Dann T, Buenaventura R, Ferguson K, Atluri S, et al. Low-Dose Naltrexone Use for Patients with Chronic Regional Pain Syndrome: A Systematic Literature Review. Pain Physician. 2021;24(4):E393-E406.
11. Xu J, Yang J, Lin P, Rosenquist E, Cheng J. Intravenous Therapies for Complex Regional Pain Syndrome: A Systematic Review. Anesth Analg. 2016;122(3):843-56.
12. Kim YC, Castañeda AM, Lee CS, Jin HS, Park KS, Moon JY. Efficacy and Safety of Lidocaine Infusion Treatment for Neuropathic Pain: A Randomized, Double-Blind, and Placebo-Controlled Study. Reg Anesth Pain Med. 2018;43(4):415-24.
13. Hu Q, Wang Q, Wang C, Tai Y, Liu B, Shao X, et al. TRPV1 Channel Contributes to the Behavioral Hypersensitivity in a Rat Model of Complex Regional Pain Syndrome Type 1. Front Pharmacol. 2019;10:453.
14. Goebel A, Jacob A, Frank B, Sacco P, Alexander G, Philips C, Bassett P, Moots R. Mycophenolate for persistent complex regional pain syndrome, a parallel, open, randomised, proof of concept trial. Scand J Pain. 2018;18(1):29-37.
15. Hsiao HT, Liu YY, Wang JC, Lin YC, Liu YC. The analgesic effect of propofol associated with the inhibition of hypoxia inducible factor and inflammasome in complex regional pain syndrome. J Biomed Sci. 2019;26(1):74.
16. Das V, Kroin JS, Moric M, McCarthy RJ, Buvanendran A. Early Treatment With Metformin in a Mice Model of Complex Regional Pain Syndrome Reduces Pain and Edema. Anesth Analg. 2020;130(2):525-34.
17. David Clark J, Tawfik VL, Tajerian M, Kingery WS. Autoinflammatory and autoimmune contributions to complex regional pain syndrome. Mol Pain. 2018;14:1744806918799127.
18. Lacagnina MJ, Heijnen CJ, Watkins LR, Grace PM. Autoimmune regulation of chronic pain. Pain Rep. 2021;6(1):e905.
19. Goebel A, Jones S, Oomman S, Callaghan T, Sprotte G. Treatment of long-standing complex regional pain syndrome with therapeutic plasma exchange: a preliminary case series of patients treated in 2008-2014. Pain Med. 2014;15(12):2163-4.